Dupilumab therapy in atopic dermatitis is safe during COVID-19 infection era: A systematic review and meta-analysis of 1611 patients

Amr Ehab El-Qushayri*, Mariam Abdelmageed Mahmoud, Samar Salman, Sameh Sarsik, Beatrice Nardone

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Dupilumab therapy in atopic dermatitis is safe during COVID-19 infection era: A systematic review and meta-analysis of 1611 patients'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science